146
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Simple UHPLC-DAD Method for the Direct Determination of Donepezil in Cerebrospinal Fluid

, , , &

References

  • Kafkala, S.; Matthaiou, S.; Alexaki, P.; Abatzis, M.; Bartzeliotis, A.; Katsiabani, M. New Gradient High-performance Liquid Chromatography Method for Determination of Donepezil Hydrochloride Assay and Impurities Content in Oral Pharmaceutical Formulation. J. Chromatogr. A 2008, 1189, 392–397.
  • Parnetti, L.; Amici, S.; Lanari, A.; Romani, C.; Antognelli, C.; Andreasen, N.; Minthon, L.; Davidsson, P.; Pottel, H.; Blennow, K.; Gallai, V. Cerebrospinal Fluid Levels of Biomarkers and Activity of Acetylcholinesterase (AChE) and Butyrylcholinesterase in AD Patients Before and After Treatment with Different AChE Inhibitors. Neurol. Sci. 2002, 23, 895–896.
  • Parnetti, L.; Chiasserini, D.; Andreasson, U.; Ohlson, M.; Hüls, C.; Zetterberg, H.; Minthon, L.; Wallin, A. K.; Andreasen, N.; Talesa, V. N.; Blennow, K. Changes in CSF Acetyl- and Butyrylcholinesterase Activity After Long-term Treatment with AChE Inhibitors in Alzheimer’s Disease. Acta Neurol. Scandinavica 2011, 124, 122–129.
  • Darreh-Shori, T.; Meurling, L.; Pettersson, T.; Hugosson, K.; Hellström-Lindahl, E.; Andreasen, N.; Minthon, L.; Nordberg, A. Changes in the Activity and Protein Levels of CSF Acetylcholinesterases in Relation to Cognitive Function of Patients with Mild Alzheimer’s Disease Following Chronic Donepezil Treatment. J. Neural Transmission 2006, 113, 1791–1801.
  • Lu, Y. H.; Wen, H. M.; Li, W.; Chi, Y. M.; Zhang, Z. X. Determination of Donepezil in human Plasma by HPLC-MS. Yao Xue Xue Bao 2003, 38, 203–206.
  • Lu, Y.; Wen, H.; Li, W.; Chi, Y.; Zhang, Z. Determination of donepezil hydrochloride (E2020) in Plasma by Liquid Chromatography-mass Spectrometry and Its Application to Pharmacokinetic Studies in Healthy, Young, Chinese Subjects. J. Chromatogr. Sci. 2004, 42, 234–237.
  • Yu, Q.; Xiang, J.; Shi, L. Z.; Liang, M. Z.; Qin, Y. P.; Nan, F. Determination of Donepezil Enantiomer in Human Plasma by Normal-HPLC-MS/MS. Sichuan Da Xue Xue Bao Yi Xue Ban 2012, 43, 779–781.
  • Apostolou, C.; Dotsikas, Y.; Kousolos, C.; Loukas, Y. L. Quantitative Determination of Donepezil in Human Plasma by Liquid Chromatography/Tandem Mass Spectrometry Employing an Automated Liquid-liquid Extraction Based on 96-well Format Plates: Application to a Bioequivalence Study. J. Chromatogr. B 2007, 848, 239–244.
  • Xie, Z.; Liao, Q.; Xu, X.; Yao, M.; Wan, J.; Liu, D. Rapid and Sensitive Determination of Donepezil in Human Plasma by Liquid Chromatography/Tandem Mass Spectrometry: Application to a Pharmacokinetic Study. Rapid Commun. Mass Spectrom. 2006, 20, 3193–3198.
  • Pilli, N. R.; Inamadugu, J. K.; Kondreddy, N.; Karra, V. K.; Damaramadugu, R.; Rao, J. V. A Rapid and Sensitive LC-MS/MS Method for Quantification of Donepezil and Its Active Metabolite, 6-o-Desmethyldonepezil in Human Plasma and Its Pharmacokinetic Application. Biomed. Chromatogr. 2011, 25, 943–951.
  • Park, E. J.; Lee, H. W.; Ji, H. Y.; Kim, H. Y.; Lee, M. H.; Park, E. S.; Lee, K. C.; Lee, H. S. Hydrophilic Interaction Chromatography-tandem Mass Spectrometry of Donepezil in Human Plasma: Application to a Pharmacokinetic Study of Donepezil in Volunteers. Arch. Pharm. Res. 2008, 31, 1205–1211.
  • Koeber, R.; Kluenemann, H. H.; Waimer, R.; Koestlbacher, A.; Wittmann, M.; Brandl, R.; Doerfelt, A.; Jahner, T.; Melchner, D.; Haen, E. Implementation of a Cost-effective HPLC/UV-Approach for Medical Routine Quantification of Donepezil in Human Serum. J. Chromatogr. B 2012, 881–882, 1–11.
  • Yasui-Furukori, N.; Furuya, R.; Takahata, T.; Tateishi, T. Determination of Donepezil, an Acetylcholinesterase Inhibitor, in Human Plasma by High-performance Liquid Chromatography with Ultraviolet Absorbance Detection. J. Chromatogr. B 2002, 768, 261–265.
  • Abonassif, M. A.; Hefnawy, M. M.; Kassem, M. G.; Mostafa, G. A. Determination of Donepezil Hydrochloride in Human Plasma and Pharmaceutical Formulations by HPLC with Fluorescence Detection. Acta. Pharm. 2011, 61, 403–413.
  • Nakashima, K.; Itoh, K.; Kono, M.; Nakashima, M. N.; Wada, M. Determination of Donepezil Hydrochloride in Human and Rat Plasma, Blood and Brain Microdialysates by HPLC with a Short C30 Column. J. Pharm. Biomed. Anal. 2006, 41, 201–206.
  • Radwan, M. A.; Abdine, H. H.; Al-Quadeb, B. T.; Aboul-Enein, H. Y.; Nakashima, K. Stereoselective HPLC Assay of Donepezil Enantiomers with UV Detection and Its Application to Pharmacokinetics in Rats. J. Chromatogr. B 2006, 830, 114–119.
  • Noetzli, M.; Ansermot, N.; Dobrinas, M.; Eap, C. B. Simultaneous Determination of Antidementia Drugs in Human Plasma: Procedure Transfer from HPLC-MS to UPLC-MS/MS. J. Pharm. Biomed. Anal. 2012, 64–65, 16–25.
  • García-Ayllón, M. S.; Silveyra, M. X.; Andreasen, N.; Brimijoin, S.; Blennow, K.; Sáez-Valero, J. Cerebrospinal Fluid Acetylcholinesterase Changes After Treatment with Donepezil in Patients with Alzheimer’s Disease. J. Neurochem. 2007, 01, 1701–1711.
  • Nordberg, A.; Darreh-Shori, T.; Peskind, E.; Soininen, H.; Mousavi, M.; Eagle, G.; Lane, R. Different Cholinesterase Inhibitor Effects on CSF Cholinesterases in Alzheimer Patients. Curr. Alzheimer Res. 2009, 6, 4–14.
  • Guidance for Industry. Bioanalytical Method Validation. FDA, September 2013. www.fda.gov/downloads/Drugs/Guidances/ucm070107.pdf (accessed Mar, 2014)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.